﻿<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Explor Asthma Allergy</journal-id>
<journal-id journal-id-type="publisher-id">EAA</journal-id>
<journal-title-group>
<journal-title>Exploration of Asthma &amp; Allergy</journal-title>
</journal-title-group>
<issn pub-type="epub">2837-5076</issn>
<publisher>
<publisher-name>Open Exploration Publishing</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.37349/eaa.2024.00036</article-id>
<article-id pub-id-type="manuscript">100936</article-id>
<article-categories>
<subj-group>
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Food protein-induced enterocolitis syndrome in adults: review and practice recommendations</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1192-8475</contrib-id>
<name>
<surname>González-Delgado</surname>
<given-names>Purificación</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing—original draft</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<role content-type="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8937-7311</contrib-id>
<name>
<surname>Entrala</surname>
<given-names>Ana</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing—original draft</role>
<xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-2875-486X</contrib-id>
<name>
<surname>Nuñez-Orjales</surname>
<given-names>Ramon</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing—original draft</role>
<xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-2317-5359</contrib-id>
<name>
<surname>Marchan</surname>
<given-names>Eva</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing—original draft</role>
<xref ref-type="aff" rid="I6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1065-7199</contrib-id>
<name>
<surname>Fernández</surname>
<given-names>Javier</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role content-type="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0960-9854</contrib-id>
<name>
<surname>Nowak-Wegrzyn</surname>
<given-names>Anna</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing—original draft</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<role content-type="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<xref ref-type="aff" rid="I7">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="I8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="editor">
<name>
<surname>Ridolo</surname>
<given-names>Erminia</given-names>
</name>
<role>Academic Editor</role>
<aff>University of Parma, Italy</aff>
</contrib>
</contrib-group>
<aff id="I1">
<sup>1</sup>Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain</aff>
<aff id="I2">
<sup>2</sup>Clinical Medicine Department, University Miguel Hernández, 03202 Alicante, Spain</aff>
<aff id="I3">
<sup>3</sup>Allergy Department, General University Hospital, 03010 Alicante, Spain</aff>
<aff id="I4">
<sup>4</sup>Allergy Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain</aff>
<aff id="I5">
<sup>5</sup>Allergy Department, Hospital Universitario Lucus Augusti, 27003 Lugo, Spain</aff>
<aff id="I6">
<sup>6</sup>Allergy Department, Complejo Hospitalario Universitario de Toledo, 45007 Toledo, Spain</aff>
<aff id="I7">
<sup>7</sup>Department of Pediatrics, NYU Grossman School of Medicine, Hassenfeld Children’s Hospital, New York, NY 10016, USA</aff>
<aff id="I8">
<sup>8</sup>Department of Pediatrics, Gastroenterology and Nutrition, Collegium Medicum, University of Warmia and Mazury, 10719 Olsztyn, Poland</aff>
<author-notes>
<corresp id="cor1">
<sup>*</sup>
<bold>Correspondence:</bold> Purificación González-Delgado, Allergy Department, General University Hospital, C/Pintor Baeza 11, 03010 Alicante, Spain. <email>purifica60@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>04</month>
<year>2024</year>
</pub-date>
<volume>2</volume>
<issue>2</issue>
<fpage>148</fpage>
<lpage>160</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>10</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2024.</copyright-statement>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract>
<p id="absp-1">Food protein-induced enterocolitis syndrome (FPIES) is an allergic disorder that manifests as reproducible gastrointestinal symptoms within hours of ingestion of the causative food, which can progress to dehydration and hypotension. Historically, FPIES has been recognized as a disease affecting the pediatric population but it can also develop <italic>de novo</italic> in adults. The pathophysiology is not well understood; however, the local adaptive immune system and gene expression linked to innate immune activation are implicated. Adult-onset FPIES has some differences with pediatric FPIES. Vomiting may be absent, while abdominal pain is the most common manifestation. A clear predominance in women occurs, being seafood the most common trigger, although many other foods have also been implicated. Diagnosis of adult-onset FPIES is based on a thorough clinical history but in many cases, it should be followed by an oral food challenge (OFC), due to the absence of vomiting in some patients and the lack of confirmatory diagnostic test. The first-line treatment for acute FPIES reactions is fluid replacement, by the oral route in mild to moderate reactions or via the intravenous route in severe reactions. Ondansetron may be effective in shortening the duration of emesis. Management of patients after diagnosis includes dietary advice and follow-up with supervised OFC at regular intervals to monitor for resolution. Tolerance to the trigger food in children is commonly achieved, a finding not so common in adult-onset FPIES. The aim of this article is to review the most important current concepts in epidemiology, pathophysiology, diagnosis, and management of FPIES.</p>
</abstract>
<kwd-group>
<kwd>Food protein-induced enterocolitis</kwd>
<kwd>food protein-induced enterocolitis syndrome</kwd>
<kwd>adult food protein-induced enterocolitis syndrome</kwd>
<kwd>non-immunoglobulin E mediated food allergy</kwd>
<kwd>irritable bowel disease</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p id="p-1">Food protein-induced enterocolitis syndrome (FPIES) is a non-immunoglobulin E (IgE) mediated food allergy, which normally debuts in infancy and childhood and manifests as repetitive vomiting, sometimes followed by diarrhea. It can be accompanied by lethargy, hypotonia, hypothermia, and hypotension [<xref ref-type="bibr" rid="B1">1</xref>].</p>
<p id="p-2">In recent years, an increasing number of cases of adult-onset FPIES have been described; however, data from these reports suggest some differences with pediatric FPIES [<xref ref-type="bibr" rid="B2">2</xref>–<xref ref-type="bibr" rid="B11">11</xref>], so the diagnostic criteria proposed in the international consensus may lead to underdiagnosis in adults.</p>
<p id="p-3">This review aims to describe clinical characteristics, epidemiology, and differences between adult and pediatric FPIES and to propose diagnostic criteria to improve the diagnosis in adults.</p>
</sec>
<sec id="s2">
<title>Epidemiology and prevalence</title>
<p id="p-4">Powell [<xref ref-type="bibr" rid="B12">12</xref>] first described FPIES in 1976, but it was not until 2015 that FPIES was recognized and codified in the International Classification of Diseases, 10th edition (ICD-10, code K52.2). Although FPIES is regarded as a rare food allergy disorder, the prevalence reported for children in the USA is 0.51% [<xref ref-type="bibr" rid="B13">13</xref>], a figure in line with other studies from Israel and Spain [<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>]. In adults, a cross-sectional, population-based survey of the USA population carried out by Nowak-Wegrzyn et al. [<xref ref-type="bibr" rid="B13">13</xref>] from 2015 to 2016 estimated a prevalence of 0.22% [95% confidential interval (CI), 0.17–0.28] based on data from 40,443 adults, 113 of whom reported physician-diagnosed FPIES.</p>
<p id="p-5">The true prevalence of adult FPIES is likely underestimated due to the combination of underdiagnosis, under-reporting, and non-attendance to healthcare centers for mild cases. In fact, adult case series report a median of 5 episodes to 10 episodes prior to diagnosis, with a median delay of four years [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>]. Regional variations in prevalence may also occur, as described in children [<xref ref-type="bibr" rid="B16">16</xref>].</p>
<p id="p-6">Prevalence data for chronic FPIES are unknown and complicated by the similar clinical presentation to food protein enteropathies in childhood [<xref ref-type="bibr" rid="B17">17</xref>]. In adults, the disease is rarely recognized, and only one clinical case was communicated in the literature in 2020 [<xref ref-type="bibr" rid="B18">18</xref>].</p>
<p id="p-7">The average age at the onset of adult FPIES is around 35 years but may present anytime from the late teenage years to old age. A clear predominance of women has been observed in all adult series reported (<xref ref-type="table" rid="t1">Table 1</xref>). Moreover, most series show high rates of atopic diseases, especially IgE mediated food allergy, rhinitis, asthma, and atopic dermatitis, in adults with FPIES, similar to children [<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B9">9</xref>–<xref ref-type="bibr" rid="B11">11</xref>].</p>
<table-wrap id="t1">
<label>Table 1</label>
<caption>
<p id="t1-p-1">Adult-onset FPIES series reported</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>Study</th>
<th>Sample size (<italic>n</italic>)</th>
<th>Study type</th>
<th>% Women</th>
<th>Mean age at 1st reaction (years)</th>
<th>Emergency department visits (%)</th>
<th>Foods</th>
<th>Patients who reacted to &gt; 1 food or food group</th>
<th>Patients with other atopic diseases associated with FPIES (%)</th>
<th>Patients with sIgE to the trigger food (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tan and Smith [<xref ref-type="bibr" rid="B3">3</xref>] (2014, Australia)</td>
<td>31</td>
<td>Prospective</td>
<td>77%</td>
<td>29</td>
<td>6%</td>
<td>Crustaceans, mollusks, fish, and egg</td>
<td>16%</td>
<td>52%</td>
<td>0%</td>
</tr>
<tr>
<td>Du et al. [<xref ref-type="bibr" rid="B5">5</xref>] (2018, Canada)</td>
<td>20</td>
<td>Retrospective</td>
<td>90%</td>
<td>38</td>
<td>-</td>
<td>Shellfish, dairy, wheat, and egg</td>
<td>30%</td>
<td>25%</td>
<td>0%</td>
</tr>
<tr>
<td>Gonzalez-Delgado et al. [<xref ref-type="bibr" rid="B6">6</xref>] (2019, Spain)</td>
<td>25</td>
<td>Prospective</td>
<td>88%</td>
<td>28</td>
<td>-</td>
<td>Crustaceans, fish, cephalopods, and bivalves</td>
<td>40%</td>
<td>72%</td>
<td>0%</td>
</tr>
<tr>
<td>Li et al. [<xref ref-type="bibr" rid="B7">7</xref>] (2020, Canada)</td>
<td>19</td>
<td>Retrospective</td>
<td>68%</td>
<td>34</td>
<td>16%</td>
<td>Crustaceans</td>
<td>-</td>
<td>28%</td>
<td>5%</td>
</tr>
<tr>
<td>Crespo et al. [<xref ref-type="bibr" rid="B8">8</xref>] (2021, Spain)</td>
<td>24</td>
<td>Prospective and retrospective</td>
<td>71%</td>
<td>37</td>
<td>33%</td>
<td>Mollusks, crustaceans, fish, oats, and bean</td>
<td>42%</td>
<td>50%</td>
<td>8%</td>
</tr>
<tr>
<td>García Paz et al. [<xref ref-type="bibr" rid="B9">9</xref>] (2023, Spain)</td>
<td>28</td>
<td>Retrospective</td>
<td>75%</td>
<td>32</td>
<td>-</td>
<td>Bivalves, crustaceans, and fish</td>
<td>7%</td>
<td>50%</td>
<td>7%</td>
</tr>
<tr>
<td>González-Delgado et al. [<xref ref-type="bibr" rid="B10">10</xref>] (2022, Spain)</td>
<td>107</td>
<td>Prospective</td>
<td>94%</td>
<td>30</td>
<td>14%</td>
<td>Crustaceans, fish, bivalves, cephalopods, and egg</td>
<td>44%</td>
<td>65%</td>
<td>4%</td>
</tr>
<tr>
<td>Crespo et al. [<xref ref-type="bibr" rid="B11">11</xref>] (2022, Spain)</td>
<td>42</td>
<td>Prospective and retrospective</td>
<td>83%</td>
<td>40</td>
<td>21%</td>
<td>Shellfish, fish, vegetables, mushroom, and egg</td>
<td>14%</td>
<td>60%</td>
<td>3%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t1-fn-1">-: not reported. sIgE: specific IgE</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p id="p-8">A higher incidence of gastrointestinal disorders including eosinophilic esophagitis, inflammatory bowel disease, and celiac disease has also been reported in the adult population [<xref ref-type="bibr" rid="B10">10</xref>]. As awareness of FPIES grows, future studies will probably report higher incidence rates, especially in the adult population.</p>
</sec>
<sec id="s3">
<title>Pathophysiology</title>
<p id="p-9">The mechanism(s) behind the characteristic symptoms of FPIES is unknown, although some evidence indicates the involvement of the immune system [<xref ref-type="bibr" rid="B19">19</xref>–<xref ref-type="bibr" rid="B26">26</xref>]. However, these studies were performed in children; there are no data on the adult population.</p>
<sec id="t3-1">
<title>Humoral immunity</title>
<p id="p-10">In adult FPIES, skin tests are usually negative, and food-sIgE is negative or low. Although some children with positive IgE evolve to have a classic IgE mediated disease [<xref ref-type="bibr" rid="B27">27</xref>], this has not been reported in adults [<xref ref-type="bibr" rid="B3">3</xref>–<xref ref-type="bibr" rid="B11">11</xref>]. Moreover, there is a working assumption that type I hypersensitivity has no role in the pathophysiology. In the early research on the disease mechanisms, some authors tried to show the possible implication of food-specific antibodies other than IgE, but casein-specific IgG, IgG1, IgG4, IgM, and IgA levels were not elevated in children with active disease compared with controls in whom the disease was resolved [<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>].</p>
</sec>
<sec id="t3-2">
<title>Cellular immunity</title>
<p id="p-11">Given the lack of a consistent antibody response, FPIES is traditionally considered a cell-mediated disease. Duodenal biopsies in affected children show increased mononuclear cells and tumor necrosis factor (TNF)-α expression in the epithelial cells [<xref ref-type="bibr" rid="B21">21</xref>]. TNF-α is known to increase intestinal permeability, and it can play a significant role in some FPIES symptoms [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>], as can diminished levels of transforming growth factor β (TGF-β) [<xref ref-type="bibr" rid="B19">19</xref>].</p>
<p id="p-12">Morita et al. [<xref ref-type="bibr" rid="B22">22</xref>] showed that reactivated peripheral blood mononuclear cells (PBMCs) in patients with non-IgE cow’s milk allergy produced high levels of T helper type 2 (Th2) and Th1 cytokines. Caubet et al. [<xref ref-type="bibr" rid="B20">20</xref>] also evaluated PBMC cytokine responses to casein stimulation, comparing milk FPIES <italic>versus</italic> IgE mediated milk allergy <italic>versus</italic> outgrown IgE mediated milk allergy. They reported that TNF-α, interleukin 6 (IL-6), and Th2 cytokines were produced in response to casein stimulation in FPIES individuals. However, this response was also observed in current and outgrown IgE mediated milk allergy.</p>
<p id="p-13">In a preliminary study of intestinal biopsy samples, Adel-Patient et al. [<xref ref-type="bibr" rid="B23">23</xref>] reported activated Th1, Th2, and Th17 cells in the mucosa of an FPIES patient, suggesting the involvement of the local adaptive immune system in the pathophysiology of the disease. This may explain the specificity of the clinical response. They also observed the presence of other cell types, including innate lymphoid cells (ILCs), in line with the recently reported systemic antigen-specific activation of innate cells associated with a positive food challenge [<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>].</p>
<p id="p-14">Furthermore, Goswami et al. [<xref ref-type="bibr" rid="B24">24</xref>] demonstrated profound activation of monocytes, neutrophils, natural killer cells, and eosinophils after oral food challenge (OFC), which might contribute to FPIES symptoms. Likewise, Mehr et al. [<xref ref-type="bibr" rid="B25">25</xref>] also communicated the expression of genes related to innate immune activation, including matrix metallopeptidase 9 (responsible for neutrophil migration), IL-1B, intercellular adhesion molecule, signal transducer, and activator of transcription-3, during positive OFC. Berin et al. [<xref ref-type="bibr" rid="B26">26</xref>] corroborated these findings, reporting that symptomatic FPIES challenges were associated with significant elevation of cytokines and chemokines, including IL-17 family markers, T cell activation (IL-2), and innate inflammatory markers. Mass cytometry demonstrated activation of non-conventional T cell populations, including γδ T cells and CD3+CD4–CD8–CD161+ cells.</p>
<p id="p-15">Using a CD154-based detection approach, Goswami et al. [<xref ref-type="bibr" rid="B24">24</xref>] could not identify an antigen-specific T cell response in FPIES, though they observed a global loss of lymphocytes from the peripheral circulation following positive OFC.</p>
<p id="p-16">These data do not necessarily rule out a role for T cells in FPIES. It is possible that antigen-specific cells can be located in the gastrointestinal tract and do not recirculate [<xref ref-type="bibr" rid="B26">26</xref>].</p>
</sec>
<sec id="t3-3">
<title>Gut microbiota</title>
<p id="p-17">There is little research on gut microbiota alterations in non-IgE mediated food allergy disorders. Boyer and Scuderi [<xref ref-type="bibr" rid="B28">28</xref>] reported that the microbiota from stool in infants with FPIES was enriched with bacteria from the Gammaproteobacteria and Porphyromonadaceae families. Caparrós et al. [<xref ref-type="bibr" rid="B29">29</xref>] also reported a different gut microbial signature in FPIES patients compared with controls. Further gut microbiome research is required to know the precise mechanism of intestinal dysbiosis in FPIES.</p>
</sec>
<sec id="t3-4">
<title>Neuroendocrine activation</title>
<p id="p-18">A growing body of evidence supports a role for serotonin, a key mediator of the gut-brain axis, in the pathogenesis of FPIES. Ondansetron, a selective 5-hydroxytryptamine type-3 (5-HT3) antagonist, seems to improve the symptoms of acute FPIES [<xref ref-type="bibr" rid="B30">30</xref>]. Serotonin also interferes with the balance between Th17 and regulatory T cells [<xref ref-type="bibr" rid="B31">31</xref>]. Furthermore, the rise in serotonin activates cholinergic enteric and vagus nerves, causing increased intestinal motility [<xref ref-type="bibr" rid="B32">32</xref>].</p>
</sec>
</sec>
<sec id="s4">
<title>Clinical presentation</title>
<p id="p-19">In adults, FPIES symptoms generally appear after years of previous tolerance, but in some cases, symptoms begin in childhood and persist into adulthood. Currently, no risk factors associated with the development of adult FPIES have been identified, though some authors have speculated that the loss of oral tolerance may be due to environmental influences like diet, use of antimicrobials, infections, pollutants, and detergents driving a shift towards microbial dysbiosis and immune dysregulation [<xref ref-type="bibr" rid="B33">33</xref>]. The classic presentation of acute FPIES in children consists of profuse vomiting within 1 h to 4 h after ingestion of the suspected food, accompanied by pallor and lethargy; however, in adults, the onset of symptoms may be delayed up to 6 h [<xref ref-type="bibr" rid="B11">11</xref>].</p>
<p id="p-20">The clinical presentation of FPIES in adults differs considerably from that of children, especially with regard to the presence of vomiting. With the exception of the series by García Paz et al. [<xref ref-type="bibr" rid="B9">9</xref>] (where all patients reported this symptom), the most recent published series estimates that only about 64.5% of adults with FPIES experience vomiting (<xref ref-type="table" rid="t2">Table 2</xref>). The heterogeneous inclusion criteria between the various studies may explain these differences. In adults, the predominant symptom in the published series is abdominal pain, followed by diarrhea. Only around 30% of adult patients experience all three symptoms [<xref ref-type="bibr" rid="B5">5</xref>]. Nausea is also common, with 69% of adults reporting this in the Crespo et al. [<xref ref-type="bibr" rid="B8">8</xref>] series. Other frequent symptoms in adults include weakness (50%), chills (29%), and lethargy (26%). However, hypothermia, hypotension, and dehydration are less common in adults than in children [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>]. Reactions usually resolve within approximately 15 h (range 4–48 h) [<xref ref-type="bibr" rid="B11">11</xref>].</p>
<table-wrap id="t2">
<label>Table 2</label>
<caption>
<p id="t2-p-1">The most common symptoms reported in adults</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Case series</bold>
</th>
<th>
<bold>Sample size (<italic>n</italic>)</bold>
</th>
<th>
<bold>Abdominal pain</bold>
</th>
<th>
<bold>Vomiting</bold>
</th>
<th>
<bold>Diarrhea</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tan and Smith [<xref ref-type="bibr" rid="B3">3</xref>] 2014</td>
<td>31</td>
<td>77.4%</td>
<td>71.0%</td>
<td>58.1%</td>
</tr>
<tr>
<td>Gleich et al. [<xref ref-type="bibr" rid="B4">4</xref>] 2016</td>
<td>8</td>
<td>87.5%</td>
<td>62.5%</td>
<td>75%</td>
</tr>
<tr>
<td>Du et al. [<xref ref-type="bibr" rid="B5">5</xref>] 2018</td>
<td>20</td>
<td>90%</td>
<td>50%</td>
<td>55%</td>
</tr>
<tr>
<td>Gonzalez-Delgado et al. [<xref ref-type="bibr" rid="B6">6</xref>] 2019</td>
<td>25</td>
<td>100%</td>
<td>64%</td>
<td>76%</td>
</tr>
<tr>
<td>Crespo et al. [<xref ref-type="bibr" rid="B8">8</xref>] 2021</td>
<td>24</td>
<td>87.5%</td>
<td>75%</td>
<td>91.6%</td>
</tr>
<tr>
<td>García Paz et al. [<xref ref-type="bibr" rid="B9">9</xref>] 2023</td>
<td>28</td>
<td>89.3%</td>
<td>100%</td>
<td>89.3%</td>
</tr>
<tr>
<td>Crespo et al. [<xref ref-type="bibr" rid="B11">11</xref>] 2022</td>
<td>42</td>
<td>71.4%</td>
<td>59.5%</td>
<td>92.9%</td>
</tr>
<tr>
<td>González-Delgado [<xref ref-type="bibr" rid="B10">10</xref>] 2022</td>
<td>107</td>
<td>96.3%</td>
<td>60.7%</td>
<td>71.9%</td>
</tr>
</tbody>
</table>
</table-wrap>
<p id="p-21">The chronic form of FPIES, less common and less well known than the acute form, has been described in infants and is characterized by chronic emesis, watery diarrhea, and failure to thrive [<xref ref-type="bibr" rid="B17">17</xref>]. This form has scarcely been described in adults but is associated with weight loss, chronic diarrhea, and episodic vomiting, with some unrelated foods implicated as triggering symptoms [<xref ref-type="bibr" rid="B18">18</xref>]. This form in adults is probably frequently misdiagnosed as irritable bowel disease.</p>
</sec>
<sec id="s5">
<title>Trigger foods</title>
<p id="p-22">Crustaceans, fish, bivalves, and cephalopods are the common triggers described in different adult populations of Australia, Canada, and Spain [<xref ref-type="bibr" rid="B3">3</xref>–<xref ref-type="bibr" rid="B11">11</xref>]. However, in recent years many other foods have also been reported, including eggs, fruits (e.g., avocado, banana), oats, and other foods that are not usually implicated in IgE mediated reactions, like mushrooms, meats, garlic, and red pepper. It seems that any food may be implicated, suggesting the emergence of new triggers or possibly a higher index of suspicion [<xref ref-type="bibr" rid="B10">10</xref>].</p>
<p id="p-23">Du et al. [<xref ref-type="bibr" rid="B5">5</xref>] reported that up to 20% of patients in a series of 25 had symptoms with wheat, and in the Crespo et al. [<xref ref-type="bibr" rid="B11">11</xref>] series, up to 4.8% reported symptoms after eating oats. In cases where cereals are the triggers, lack of awareness probably results in patients being underdiagnosed or misdiagnosed with non-celiac gluten sensitivity.</p>
<p id="p-24">As with cereals, some patients initially labeled as lactose intolerant showed on OFC that milk can also induce FPIES symptoms [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B10">10</xref>]; however, in adults, most cases of milk FPIES are probably labeled as lactose intolerance.</p>
<p id="p-25">In some patients, more than one group of unrelated foods are responsible for symptoms, ranging from 7% in García Paz et al. [<xref ref-type="bibr" rid="B9">9</xref>] series to 44% in Crespo et al. [<xref ref-type="bibr" rid="B11">11</xref>]. The most common association observed was between different seafoods, such as crustaceans, mollusks, and cephalopods [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>]. This clustering pattern has also been observed in the pediatric population, probably due to taxonomical relationships [<xref ref-type="bibr" rid="B34">34</xref>].</p>
</sec>
<sec id="s6">
<title>Other differences between adult and pediatric FPIES</title>
<p id="p-26">The lack of vomiting observed in many adults with FPIES is not the only difference with respect to children (<xref ref-type="table" rid="t3">Table 3</xref>). Unlike the pediatric population, in adults, there is a clear predominance of women in all the series reported [<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B5">5</xref>–<xref ref-type="bibr" rid="B11">11</xref>]. A hormonal influence has been postulated, although a recent study failed to demonstrate this fact [<xref ref-type="bibr" rid="B10">10</xref>]. The profile of implicated foods constitutes another difference between the pediatric and adult population. This might be a result of different dietary patterns; however, in older children as in adults, seafood is an important trigger [<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>].</p>
<table-wrap id="t3">
<label>Table 3</label>
<caption>
<p id="t3-p-1">Comparison of FPIES in children and adults</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Variable</bold>
</th>
<th>
<bold>Children</bold>
</th>
<th>
<bold>Adults</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Prevalence (USA)</td>
<td>0.34–0.70%</td>
<td>0.22%</td>
</tr>
<tr>
<td>Risk factors</td>
<td>Genetic: trisomy 21, father or sibling with FPIES; Environmental: birth via cesarean section, perinatal antibiotics, gut dysbiosis, and timing and pattern of solid food introduction in infancy [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B16">16</xref>]</td>
<td>Unknown</td>
</tr>
<tr>
<td>Sex</td>
<td>Equal or slight male predominance</td>
<td>Female 80%</td>
</tr>
<tr>
<td>Food triggers</td>
<td>Cow’s milk, oat, rice, egg, peanut, fish, avocado, and sweet potato</td>
<td>Seafood (shellfish and fish); rarely cow’s milk, egg, and wheat</td>
</tr>
<tr>
<td>Symptoms</td>
<td>Repetitive, projectile emesis, lethargy, and pallor</td>
<td>Severe abdominal pain, vomiting, and diarrhea</td>
</tr>
<tr>
<td>Time to onset of symptoms</td>
<td>1–4 h</td>
<td>1–6 h</td>
</tr>
<tr>
<td>Atypical FPIES (IgE-food sensitization)</td>
<td>About 5–20%</td>
<td>&lt; 5%</td>
</tr>
<tr>
<td>Progression to immediate IgE mediated reactions in those with atypical FPIES</td>
<td>Reported by Onesimo et al. [<xref ref-type="bibr" rid="B27">27</xref>]</td>
<td>Not reported</td>
</tr>
<tr>
<td>Chronic FPIES</td>
<td>About 10%</td>
<td>Unknown, only 1 case published [<xref ref-type="bibr" rid="B16">16</xref>]</td>
</tr>
<tr>
<td>Natural history</td>
<td>Generally favorable, majority resolve by age 3–5, except fish FPIES, only 30–40% resolve by age 3–5<break />Peanut FPIES, unknown natural history</td>
<td>Less favorable</td>
</tr>
<tr>
<td>Allergic comorbidities</td>
<td>High</td>
<td>High</td>
</tr>
</tbody>
</table>
</table-wrap>
<p id="p-27">The severity of the disease also seems to differ between populations. Up to 31% of children were treated in the emergency department in Caubet et al. [<xref ref-type="bibr" rid="B37">37</xref>] series, while just 6.4% to 21.1% of adults required emergency care in the published series [<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>]. However, variations in the severity of FPIES are difficult to prove due to the many confounders. For example, adults carry less risk of food transgressions than children. Moreover, care seeking may be more frequent at the pediatric age, regardless of the severity of the reaction.</p>
<p id="p-28">There are no published cases of adults treated in intensive care unit, unlike the pediatric population. Dehydration and metabolic changes also seem uncommon in adults; however, some severe cases have been reported [<xref ref-type="bibr" rid="B2">2</xref>–<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>].</p>
<p id="p-29">OFC outcomes also provide information about disease severity. In the largest adult series, 31 of 49 OFCs were positive, and only 33.3% of cases required treatment [<xref ref-type="bibr" rid="B10">10</xref>]. In the same series, 12.9% presented hypotension, weakness, and lethargy as a reaction to fish and eggs, in addition to digestive symptoms [<xref ref-type="bibr" rid="B10">10</xref>].</p>
<p id="p-30">In another recent series [<xref ref-type="bibr" rid="B11">11</xref>], 9 of 21 OFCs were positive; in addition to digestive symptoms, three patients presented lethargy and three chills. Strikingly, none had emesis, and only four received intravenous saline solution. These data contrast with Wang et al. [<xref ref-type="bibr" rid="B38">38</xref>] results in a large pediatric population, in whom 169 OFCs were performed and 30 were positive; up to 50% of the children required intravenous fluid, and 3 required hospitalizations, including one in the intensive care unit. However, as Crespo et al. [<xref ref-type="bibr" rid="B11">11</xref>] note, adults with a history of severe symptoms often refuse OFC.</p>
<p id="p-31">The natural history of the syndrome may also differ by age. Although in adults this is not well known, some authors have described a worse prognosis than in children [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>].</p>
<p id="p-32">Otherwise, unlike the pediatric population, in which up to 20% of patients may show sIgE, especially in milk-induced FPIES, the percentage in adults is lower. Around 4% of patients showed sIgE to the offending food [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>]. Skin testing or sIgE can be considered in patients with FPIES at follow-up visits before OFC; however, the prognostic value in adults is unknown.</p>
</sec>
<sec id="s7">
<title>Diagnosis</title>
<p id="p-33">As in the pediatric population, diagnosis is based on a clinical history of typical signs and symptoms after the ingestion of the trigger food and remission after avoiding it. In the clinical history, aspects like reproducibility of symptoms after exposure, symptoms with other foods, and the latency period must be considered. In most cases, the first episodes are misdiagnosed as viral gastroenteritis or food poisoning.</p>
<p id="p-34">In a significant percentage of adults, the main diagnostic criteria proposed in the international consensus [<xref ref-type="bibr" rid="B1">1</xref>], vomiting, is absent, while abdominal pain or cramping is the most common finding, usually associated with nausea or diarrhea. Due to the lack of any specific biomarkers for diagnosing and monitoring the disease, and given the unspecific nature of symptoms, a thorough clinical history should be followed by an OFC to confirm the diagnosis of FPIES in adults.</p>
<p id="p-35">If no food transgressions have occurred over several previous years, an OFC should be performed at regular intervals to determine whether the disease has resolved.</p>
<p id="p-36">In patients with multiple implicated foods and recurrent symptoms, a gastroenterology study is recommended. Once other causes are excluded, an elimination period for suspected triggers, followed by an OFC to confirm the diagnosis is recommended.</p>
<p id="p-37">Differential diagnosis must consider anisakiasis; food poisoning; fructose, lactose, and sorbitol intolerances; and celiac disease (<xref ref-type="table" rid="t4">Table 4</xref>). In cases where multiple foods trigger FPIES symptoms, differential diagnosis with irritable bowel diseases may be difficult.</p>
<table-wrap id="t4">
<label>Table 4</label>
<caption>
<p id="t4-p-1">Differential diagnosis of FPIES in adults</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Diseases</bold>
</th>
<th>
<bold>Signs and symptoms that can distinguish the condition from FPIES</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Small intestinal bacterial overgrowth (SIBO)</td>
<td>Bloating, flatulence, and abdominal discomfort with diarrhea or constipation. Diagnosis with a carbohydrate breath test or jejunal aspirate culture</td>
</tr>
<tr>
<td>Inflammatory bowel disease</td>
<td>Diarrhea, abdominal pain, rectal bleeding, and weight loss, but not related to intake of a specific food</td>
</tr>
<tr>
<td>Irritable bowel syndrome (IBS)</td>
<td>Abdominal pain and changes in bowel habits (constipation and/or diarrhea) and in stool form</td>
</tr>
<tr>
<td>Lactose intolerance</td>
<td>Bloating, cramps, diarrhea, borborygmi, and vomiting after ingestion of milk or dairy products with lactose</td>
</tr>
<tr>
<td>Fructose intolerance</td>
<td>Bloating, flatulence, or diarrhea after ingestion of fruit and fruit-based sweeteners</td>
</tr>
<tr>
<td>Celiac disease</td>
<td>No temporal relationship between symptoms and specific food intake, progressive malabsorption, and positive celiac serology</td>
</tr>
<tr>
<td>Eosinophilic gastroenteritis</td>
<td>Symptoms more chronic than episodic, vomiting less severe, and more likely to have positive IgE test results, usually not associated with specific food intake</td>
</tr>
<tr>
<td>FPIES</td>
<td>Abdominal pain, diarrhea, vomiting related to specific foods (especially seafood, eggs, etc.)</td>
</tr>
<tr>
<td>Intolerance of short-chain fermentable carbohydrates</td>
<td>Flatulence, abdominal pain, bloating, or diarrhea after foods containing fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) is variably referred to as carbohydrate intolerance</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="t7-1">
<title>OFC procedures</title>
<p id="p-38">Although episodes in adults seem less severe than in children, OFC should be performed in a medically supervised setting with access to intravenous rehydration, as some patients may develop repetitive vomiting and dehydration.</p>
<p id="p-39">The total dose and dosing regimen for FPIES-related OFCs have not been systematically studied, so practices vary. Publications on procedures in adults are scarce because most studies are retrospective, and OFC is performed only in a small number of patients [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>].</p>
<p id="p-40">The international consensus proposes administering the challenge food, usually 0.3 g of the food protein per kilogram of body weight, in three equal doses over 30 min [<xref ref-type="bibr" rid="B1">1</xref>]. Infante et al. [<xref ref-type="bibr" rid="B39">39</xref>] propose a method with a single daily dose on two non-consecutive days (25% and 100% of a serving size, respectively). Other authors [<xref ref-type="bibr" rid="B10">10</xref>] propose a shorter protocol, dividing the total serving size into two doses: 25% of the total amount in the first dose and the rest 2 h later. In both protocols, a 4 h observation period is recommended. The recommendation is that in patients with severe symptoms, a two-day protocol is called for, while in patients with milder symptoms, the shorter protocol may be carried out. Ultimately, it is at the physician’s discretion to modify the regimen depending on the patient’s individual circumstances, as proposed by the international consensus [<xref ref-type="bibr" rid="B1">1</xref>].</p>
<p id="p-41">After OFC, a milder increase in neutrophilia was observed in adults compared with children [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>]. The absolute neutrophil count, measured from 31 positive OFCs, showed a median increase of 632.84 cells/mm<sup>3</sup> (interquartile range 300–1,300 cells/mm<sup>3</sup>). Only four patients presented with a neutrophil count of more than 1,500 cells/mm<sup>3</sup> [<xref ref-type="bibr" rid="B10">10</xref>]. These findings are similar to those reported by Crespo et al. [<xref ref-type="bibr" rid="B11">11</xref>], who observed neutrophilia in 3 out of 9 patients. Therefore, although neutrophilia is an uncommon finding, its presence supports the diagnosis.</p>
</sec>
<sec id="t7-2">
<title>Diagnostic algorithm</title>
<p id="p-42">The proposed algorithm is reflected in <xref ref-type="fig" rid="fig1">Figure 1</xref>. In patients with repeated episodes of abdominal pain, with or without nausea, vomiting, or diarrhea that appears 30 min to 6 h after the ingestion of food, and resolution of symptoms after avoiding the offending food, FPIES must be suspected. In adults, due to the nonspecific symptoms, with the absence of vomiting in a relevant percentage of cases, an OFC to confirm the diagnosis is proposed, especially in cases in which diagnosis is uncertain and also after patients have avoided the food for an interval to determine if tolerance has developed.</p>
<fig id="fig1" position="float">
<label>Figure 1</label>
<caption>
<p id="fig1-p-1">Diagnostic algorithm for adult FPIES. DBPCOFC: double-blind, placebo-controlled OFC</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="eaa-02-100936-g001.tif" />
</fig>
<p id="p-43">OFC must be carried out with the food prepared in the same manner that causes symptoms and with the appropriate doses [<xref ref-type="bibr" rid="B1">1</xref>]. In patients with recurrent symptoms in whom FPIES is suspected, a gastroenterology study is necessary to rule out other diseases such as SIBO, inflammatory bowel disease, and celiac disease, among others [<xref ref-type="bibr" rid="B40">40</xref>]. After the exclusion of other causes, a food diary may be useful to identify possible culprit foods, which can then be tested by OFC.</p>
<p id="p-44">In cases in which symptoms reported after an OFC are equivocal or difficult to evaluate, and in patients who are anxious, a DBPCOFC is advised. Collaboration between allergology and gastroenterology services is essential to diagnose FPIES, especially in patients with more than one food or group of foods implicated.</p>
</sec>
</sec>
<sec id="s8">
<title>Treatment</title>
<sec id="t8-1">
<title>Acute treatment</title>
<p id="p-45">Management of acute FPIES reactions consists of symptom-directed treatment, and the approach will differ depending on the severity of the symptoms [<xref ref-type="bibr" rid="B41">41</xref>]. First-line treatment is rehydration with fluids. For mild reactions, an oral replacement will be sufficient, whereas in moderate or severe reactions, intravenous fluid replacement (1,500–2,000 mL of physiological saline) is recommended. If nausea or vomiting occurs, the treatment of choice is orodispersible ondansetron (a serotonin 5-HT3 receptor antagonist with central and peripheral effects shown to be safer than other antiemetics) [<xref ref-type="bibr" rid="B30">30</xref>].</p>
<p id="p-46">For abdominal pain, analgesics such as paracetamol 500 mg can be used. Adrenaline is not indicated [<xref ref-type="bibr" rid="B1">1</xref>]. The use of corticosteroids is controversial and usually reserved for severe reactions. A single dose of intravenous methylprednisolone (1 mg/kg, maximum 60–80 mg) may be given in severe reactions. In life-threatening reactions, intravenous vasopressors may be necessary [<xref ref-type="bibr" rid="B41">41</xref>].</p>
</sec>
<sec id="t8-2">
<title>Adult FPIES management</title>
<p id="p-47">If FPIES is suspected, the patient should be referred to the allergist, who will make the diagnosis and recommend an avoidance diet, which will be personalized for each patient, preferably through shared decision-making. Patients are usually advised to avoid the entire food group that has produced the reaction. However, avoidance of other associated food groups (e.g., fish and shellfish), is generally not recommended unless the patient reports symptoms with both [<xref ref-type="bibr" rid="B1">1</xref>]. Some patients may benefit from an OFC with a fish or shellfish different from the causative one to avoid unnecessary restrictions.</p>
<p id="p-48">Currently, there are no biomarkers or data to help predict the development of tolerance, so OFC is the only available diagnostic tool to test tolerance and thus avoid prolonged exclusion diets. The OFC should be performed every 2–3 years, due to the relatively lower tendency of symptom remission in adults. However, some patients with severe reactions refuse the test and prefer to continue with the exclusion diet, so management should be individualized.</p>
</sec>
</sec>
<sec id="s9">
<title>Natural history</title>
<p id="p-49">Most FPIES cases with childhood-onset resolve by 3–5 years of age. Age at resolution depends mainly on the type of food. Milk and cereals are usually tolerated earlier, while the period for achieving tolerance is longer for egg and fish FPIES. However, patients with multiple FPIES triggers do not appear to become tolerant at an older age than those with a single trigger [<xref ref-type="bibr" rid="B16">16</xref>]. Data on the acquisition of tolerance in adults are scarce, but it seems to take longer than in children, and in many cases, it may be persistent [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>].</p>
<p id="p-50">Recent studies [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>] in adults have provided more insights into the natural history of FPIES in this age group. One prospective study [<xref ref-type="bibr" rid="B10">10</xref>] with a median follow-up period of 6.2 years observed that 16.8% of patients achieved tolerance after a median of 3.5 years. However, other patients in the cohort had not overcome the disease even after 40 years, a finding also described elsewhere [<xref ref-type="bibr" rid="B2">2</xref>]. An inverse correlation between disease duration and resolution was observed [<xref ref-type="bibr" rid="B10">10</xref>]. Crespo et al. [<xref ref-type="bibr" rid="B11">11</xref>] reported that in a population of 15 patients in which OFC was performed, 40% tolerated the offending food after a median of 7 years from the first reaction.</p>
</sec>
<sec id="s10">
<title>Conclusions</title>
<p id="p-51">The international consensus [<xref ref-type="bibr" rid="B1">1</xref>] provides a useful tool for the diagnosis and management of FPIES; however, a considerable proportion of adults go undiagnosed using the criteria proposed.</p>
<p id="p-52">Due to the lack of any specific biomarkers for diagnosing and monitoring the disease, and given the unspecific nature of symptoms, a thorough clinical history should be followed by an OFC to confirm the diagnosis of FPIES in adults. The latest reports [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>] confirm that in adults, some patients achieve tolerance after a period of avoidance.</p>
<p id="p-53">More studies are needed to better understand the characteristics of adult FPIES, its pathogenesis, and its natural history, and it is essential to identify a biomarker to diagnose and monitor the disease.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>FPIES</term>
<def>
<p>food protein-induced enterocolitis syndrome</p>
</def>
</def-item>
<def-item>
<term>IgE</term>
<def>
<p>immunoglobulin E</p>
</def>
</def-item>
<def-item>
<term>IL-6</term>
<def>
<p>interleukin 6</p>
</def>
</def-item>
<def-item>
<term>OFC</term>
<def>
<p>oral food challenge</p>
</def>
</def-item>
<def-item>
<term>sIgE</term>
<def>
<p>specific immunoglobulin E</p>
</def>
</def-item>
<def-item>
<term>Th2</term>
<def>
<p>T helper type 2</p>
</def>
</def-item>
<def-item>
<term>TNF</term>
<def>
<p>tumor necrosis factor</p>
</def>
</def-item>
</def-list>
</glossary>
<sec id="s11">
<title>Declarations</title>
<sec>
<title>Author contributions</title>
<p>PGD and ANW: Conceptualization, Investigation, Writing—original draft, Writing—review &amp; editing, Supervision. AE and RNO: Conceptualization, Investigation, Writing—original draft. EM: Investigation, Writing—original draft. JF: Conceptualization, Investigation, Supervision, Resources. All authors read and approved the submitted version.</p>
</sec>
<sec sec-type="COI-statement">
<title>Conflicts of interest</title>
<p>The authors declare that they have no conflicts of interest.</p>
</sec>
<sec>
<title>Ethical approval</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Consent to publication</title>
<p>Not applicable.</p>
</sec>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Funding</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Copyright</title>
<p>© The Author(s) 2024.</p>
</sec>
</sec>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nowak-Węgrzyn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chehade</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Groetch</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Spergel</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>K</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: executive summary—workgroup report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma &amp; Immunology</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2017">2017</year>
<volume>139</volume>
<fpage>1111</fpage>
<lpage>26.e4</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2016.12.966</pub-id><pub-id pub-id-type="pmid">28167094</pub-id></element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Gore</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Custovic</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Food protein-induced enterocolitis syndrome can occur in adults</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2012">2012</year>
<volume>130</volume>
<fpage>1199</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2012.06.017</pub-id><pub-id pub-id-type="pmid">22835404</pub-id></element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>WB</given-names>
</name>
</person-group>
<article-title>Non-IgE-mediated gastrointestinal food hypersensitivity syndrome in adults</article-title>
<source>J Allergy Clin Immunol Pract</source>
<year iso-8601-date="2014">2014</year>
<volume>2</volume>
<fpage>355</fpage>
<lpage>7.e1</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaip.2014.02.002</pub-id><pub-id pub-id-type="pmid">24811033</pub-id></element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gleich</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Sebastian</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Firszt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Shrimp allergy: Gastrointestinal symptoms commonly occur in the absence of IgE sensitization</article-title>
<source>J Allergy Clin Immunol Pract</source>
<year iso-8601-date="2016">2016</year>
<volume>4</volume>
<fpage>316</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaip.2015.09.020</pub-id><pub-id pub-id-type="pmid">26563673</pub-id></element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Nowak-Węgrzyn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vadas</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>FPIES in adults</article-title>
<source>Ann Allergy Asthma Immunol</source>
<year iso-8601-date="2018">2018</year>
<volume>121</volume>
<fpage>736</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.anai.2018.08.003</pub-id><pub-id pub-id-type="pmid">30121366</pub-id></element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Delgado</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Caparrós</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Cueva</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fernández</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Food protein-induced enterocolitis-like syndrome in a population of adolescents and adults caused by seafood</article-title>
<source>J Allergy Clin Immunol Pract</source>
<year iso-8601-date="2019">2019</year>
<volume>7</volume>
<fpage>670</fpage>
<lpage>2</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaip.2018.07.028</pub-id><pub-id pub-id-type="pmid">30075344</pub-id></element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Wong-Pack</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Macikunas</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Adults with possible food protein-induced enterocolitis syndrome with crustacean ingestion</article-title>
<source>Allergy Asthma Clin Immunol</source>
<year iso-8601-date="2020">2020</year>
<volume>16</volume>
<elocation-id>99</elocation-id>
<pub-id pub-id-type="doi">10.1186/s13223-020-00497-z</pub-id><pub-id pub-id-type="pmid">33292583</pub-id><pub-id pub-id-type="pmcid">PMC7659059</pub-id></element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crespo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Skrabski</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pérez-Pallise</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>De</surname>
<given-names>Castro-Martínez FJ</given-names>
</name>
<name>
<surname>Zubeldia</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Infante</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Relevant features of adult-onset food protein-induced enterocolitis syndrome</article-title>
<source>J Allergy Clin Immunol Pract</source>
<year iso-8601-date="2021">2021</year>
<volume>9</volume>
<fpage>1759</fpage>
<lpage>60.e1</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaip.2020.11.047</pub-id><pub-id pub-id-type="pmid">33290918</pub-id></element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>García</surname>
<given-names>Paz V</given-names>
</name>
<name>
<surname>Carballeira</surname>
<given-names>Anca I</given-names>
</name>
<name>
<surname>Otero</surname>
<given-names>Alonso A</given-names>
</name>
<name>
<surname>Romero</surname>
<given-names>Sánchez L</given-names>
</name>
<name>
<surname>González</surname>
<given-names>Torres L</given-names>
</name>
<name>
<surname>Vila</surname>
<given-names>Sexto L</given-names>
</name>
</person-group>
<article-title>Food protein-induced enterocolitis syndrome in an adult population from Spain</article-title>
<source>J Investig Allergol Clin Immunol</source>
<year iso-8601-date="2023">2023</year>
<volume>33</volume>
<fpage>136</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.18176/jiaci.0835</pub-id><pub-id pub-id-type="pmid">35695063</pub-id></element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>González-Delgado</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Muriel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jiménez</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cameo</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Palazón-Bru</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fernández</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Food protein-induced enterocolitis syndrome in adulthood: clinical characteristics, prognosis, and risk factors</article-title>
<source>J Allergy Clin Immunol Pract</source>
<year iso-8601-date="2022">2022</year>
<volume>10</volume>
<fpage>2397</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaip.2022.05.006</pub-id><pub-id pub-id-type="pmid">35598865</pub-id></element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crespo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pérez-Pallise</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Skrabski</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zambrano</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rojas-Pérez-Ezquerra</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Noguerado-Mellado</surname>
<given-names>B</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>The natural course of adult-onset food protein-induced enterocolitis syndrome</article-title>
<source>J Allergy Clin Immunol Pract</source>
<year iso-8601-date="2022">2022</year>
<volume>10</volume>
<fpage>2986</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaip.2022.06.013</pub-id><pub-id pub-id-type="pmid">35753669</pub-id></element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powell</surname>
<given-names>GK</given-names>
</name>
</person-group>
<article-title>Enterocolitis in low-birth-weight infants associated with milk and soy protein intolerance</article-title>
<source>J Pediatr</source>
<year iso-8601-date="1976">1976</year>
<volume>88</volume>
<fpage>840</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1016/s0022-3476(76)81128-6</pub-id><pub-id pub-id-type="pmid">944766</pub-id></element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nowak-Wegrzyn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Brown-Whitehorn</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cianferoni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schultz-Matney</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Food protein-induced enterocolitis syndrome in the US population-based study</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2019">2019</year>
<volume>144</volume>
<fpage>1128</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2019.06.032</pub-id><pub-id pub-id-type="pmid">31288044</pub-id><pub-id pub-id-type="pmcid">PMC7923683</pub-id></element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katz</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Rajuan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leshno</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The prevalence and natural course of food protein-induced enterocolitis syndrome to cow’s milk: a large-scale, prospective population-based study</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2011">2011</year>
<volume>127</volume>
<fpage>647</fpage>
<lpage>53.e3</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2010.12.1105</pub-id><pub-id pub-id-type="pmid">21377033</pub-id></element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alonso</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Ezquiaga</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Berzal</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Tardón</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>San</surname>
<given-names>José MM</given-names>
</name>
<name>
<surname>López</surname>
<given-names>PA</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Food protein-induced enterocolitis syndrome: increased prevalence of this great unknown-results of the PREVALE study</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2019">2019</year>
<volume>143</volume>
<fpage>430</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2018.08.045</pub-id><pub-id pub-id-type="pmid">30244024</pub-id></element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehr</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>DE</given-names>
</name>
</person-group>
<article-title>Food protein-induced enterocolitis syndrome: guidelines summary and practice recommendations</article-title>
<source>Med J Aust</source>
<year iso-8601-date="2019">2019</year>
<volume>210</volume>
<fpage>94</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.5694/mja2.12071</pub-id><pub-id pub-id-type="pmid">30656696</pub-id></element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powell</surname>
<given-names>GK</given-names>
</name>
</person-group>
<article-title>Milk- and soy-induced enterocolitis of infancy: clinical features and standardization of challenge</article-title>
<source>J Pediatr</source>
<year iso-8601-date="1978">1978</year>
<volume>93</volume>
<fpage>553</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/s0022-3476(78)80887-7</pub-id><pub-id pub-id-type="pmid">568171</pub-id></element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Delgado</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ruano-Zaragoza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gutierrez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Chronic adult food protein-induced enterocolitis syndrome</article-title>
<source>Ann Allergy Asthma Immunol</source>
<year iso-8601-date="2020">2020</year>
<volume>125</volume>
<fpage>716</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.anai.2020.08.009</pub-id><pub-id pub-id-type="pmid">32781242</pub-id></element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konstantinou</surname>
<given-names>GN</given-names>
</name>
<name>
<surname>Bencharitiwong</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Grishin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Caubet</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Bardina</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sicherer</surname>
<given-names>SH</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>The role of casein-specific IgA and TGF-β in children with food protein-induced enterocolitis syndrome to milk</article-title>
<source>Pediatr Allergy Immunol</source>
<year iso-8601-date="2014">2014</year>
<volume>25</volume>
<fpage>651</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1111/pai.12288</pub-id><pub-id pub-id-type="pmid">25283440</pub-id><pub-id pub-id-type="pmcid">PMC4349359</pub-id></element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caubet</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Bencharitiwong</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sampson</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Berin</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Nowak-Węgrzyn</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Humoral and cellular responses to casein in patients with food protein-induced enterocolitis to cow’s milk</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2017">2017</year>
<volume>139</volume>
<fpage>572</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2016.02.047</pub-id><pub-id pub-id-type="pmid">27545065</pub-id></element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Expression of transforming growth factor β1, transforming growth factor type I and II receptors, and TNF-α in the mucosa of the small intestine in infants with food protein–induced enterocolitis syndrome</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2002">2002</year>
<volume>109</volume>
<fpage>150</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1067/mai.2002.120562</pub-id><pub-id pub-id-type="pmid">11799382</pub-id></element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morita</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Orihara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Akasawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tachimoto</surname>
<given-names>H</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Antigen-specific T-cell responses in patients with non-IgE-mediated gastrointestinal food allergy are predominantly skewed to T<sub>H</sub>2</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2013">2013</year>
<volume>131</volume>
<fpage>590</fpage>
<lpage>2.e6</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2012.09.005</pub-id><pub-id pub-id-type="pmid">23083674</pub-id></element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adel-Patient</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lezmi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Castelli</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Blanc</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Soulaines</surname>
<given-names>P</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Deep analysis of immune response and metabolic signature in children with food protein induced enterocolitis to cow’s milk</article-title>
<source>Clin Transl Allergy</source>
<year iso-8601-date="2018">2018</year>
<volume>8</volume>
<elocation-id>38</elocation-id>
<pub-id pub-id-type="doi">10.1186/s13601-018-0224-9</pub-id><pub-id pub-id-type="pmid">30275944</pub-id><pub-id pub-id-type="pmcid">PMC6161449</pub-id></element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goswami</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Blazquez</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Kosoy</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nowak-Węgrzyn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Berin</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Systemic innate immune activation in food protein-induced enterocolitis syndrome</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2017">2017</year>
<volume>139</volume>
<fpage>1885</fpage>
<lpage>96.e9</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2016.12.971</pub-id><pub-id pub-id-type="pmid">28192147</pub-id><pub-id pub-id-type="pmcid">PMC5461215</pub-id></element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehr</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>de Jong</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bosco</surname>
<given-names>A</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Innate immune activation occurs in acute food protein-induced enterocolitis syndrome reactions</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2019">2019</year>
<volume>144</volume>
<fpage>600</fpage>
<lpage>2.e2</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2019.04.021</pub-id><pub-id pub-id-type="pmid">31059725</pub-id></element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berin</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Lozano-Ojalvo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Agashe</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Nowak-Wegrzyn</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Acute FPIES reactions are associated with an IL-17 inflammatory signature</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2021">2021</year>
<volume>148</volume>
<fpage>895</fpage>
<lpage>901.e6</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2021.04.012</pub-id><pub-id pub-id-type="pmid">33891982</pub-id><pub-id pub-id-type="pmcid">PMC8675150</pub-id></element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onesimo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dello</surname>
<given-names>Iacono I</given-names>
</name>
<name>
<surname>Giorgio</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Limongelli</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Miceli</surname>
<given-names>Sopo S</given-names>
</name>
</person-group>
<article-title>Can food protein induced enterocolitis syndrome shift to immediate gastrointestinal hypersensitivity? A report of two cases</article-title>
<source>Eur Ann Allergy Clin Immunol</source>
<year iso-8601-date="2011">2011</year>
<volume>43</volume>
<fpage>61</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="pmid">21608375</pub-id></element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Scuderi</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>P504 comparison of the gut microbiome between food protein-induced enterocolitis sydrome (FPIES) infants and allergy-free infants</article-title>
<source>Ann Allergy Asthma Immunol</source>
<year iso-8601-date="2017">2017</year>
<volume>119</volume>
<elocation-id>e3</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.anai.2017.09.070</pub-id></element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caparrós</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cenit</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Muriel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Benítez-Páez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>González-Delgado</surname>
<given-names>P</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Intestinal microbiota is modified in pediatric food protein-induced enterocolitis syndrome</article-title>
<source>J Allergy Clin Immunol Glob</source>
<year iso-8601-date="2022">2022</year>
<volume>1</volume>
<fpage>217</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacig.2022.07.005</pub-id><pub-id pub-id-type="pmid">37779539</pub-id><pub-id pub-id-type="pmcid">PMC10510020</pub-id></element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miceli</surname>
<given-names>Sopo S</given-names>
</name>
<name>
<surname>Bersani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Monaco</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cerchiara</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>D</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Ondansetron in acute food protein-induced enterocolitis syndrome, a retrospective case-control study</article-title>
<source>Allergy</source>
<year iso-8601-date="2017">2017</year>
<volume>72</volume>
<fpage>545</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1111/all.13033</pub-id><pub-id pub-id-type="pmid">27548842</pub-id></element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gil-Ad</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Korob</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Weizman</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The immunomodulatory effect of the antidepressant sertraline in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis</article-title>
<source>Neuroimmunomodulation</source>
<year iso-8601-date="2010">2010</year>
<volume>18</volume>
<fpage>117</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1159/000321634</pub-id><pub-id pub-id-type="pmid">21088435</pub-id></element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cassilly</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Jabba</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Thorpe</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>AM</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Enteroendocrine cells sense bacterial tryptophan catabolites to activate enteric and vagal neuronal pathways</article-title>
<source>Cell Host Microbe</source>
<year iso-8601-date="2021">2021</year>
<volume>29</volume>
<fpage>179</fpage>
<lpage>96.e9</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2020.11.011</pub-id><pub-id pub-id-type="pmid">33352109</pub-id><pub-id pub-id-type="pmcid">PMC7997396</pub-id></element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bingemann</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Anvari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bartnikas</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Ruffner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nowak-Wegrzyn</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Are we missing food-protein-induced enterocolitis syndrome in adults?</article-title>
<source>Ann Allergy Asthma Immunol</source>
<year iso-8601-date="2023">2023</year>
<volume>130</volume>
<fpage>269</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1016/j.anai.2022.09.029</pub-id><pub-id pub-id-type="pmid">36191851</pub-id><pub-id pub-id-type="pmcid">PMC9991959</pub-id></element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Patil</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Stockbridge</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Virkud</surname>
<given-names>YV</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>JL</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Food aversion and poor weight gain in food protein-induced enterocolitis syndrome: a retrospective study</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2020">2020</year>
<volume>145</volume>
<fpage>1430</fpage>
<lpage>7.e11</lpage>
<comment>Erratum in: J Allergy Clin Immunol. 2020;146:228.</comment>
<pub-id pub-id-type="doi">10.1016/j.jaci.2020.01.001</pub-id><pub-id pub-id-type="pmid">31940468</pub-id><pub-id pub-id-type="pmcid">PMC8360679</pub-id></element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>González-Delgado</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Caparrós</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Clemente</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Velásquez</surname>
<given-names>L</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Clinical and immunological characteristics of a pediatric population with food protein-induced enterocolitis syndrome (FPIES) to fish</article-title>
<source>Pediatr Allergy Immunol</source>
<year iso-8601-date="2016">2016</year>
<volume>27</volume>
<fpage>269</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1111/pai.12529</pub-id><pub-id pub-id-type="pmid">26681231</pub-id></element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miceli</surname>
<given-names>Sopo S</given-names>
</name>
<name>
<surname>Monaco</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Badina</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Barni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Novembre</surname>
<given-names>E</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Food protein-induced enterocolitis syndrome caused by fish and/or shellfish in Italy</article-title>
<source>Pediatr Allergy Immunol</source>
<year iso-8601-date="2015">2015</year>
<volume>26</volume>
<fpage>731</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1111/pai.12461</pub-id><pub-id pub-id-type="pmid">26287446</pub-id></element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caubet</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Sickles</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Järvinen</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Sicherer</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Sampson</surname>
<given-names>HA</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Clinical features and resolution of food protein–induced enterocolitis syndrome: 10-year experience</article-title>
<source>J Allergy Clin Immunol</source>
<year iso-8601-date="2014">2014</year>
<volume>134</volume>
<fpage>382</fpage>
<lpage>9.e4</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2014.04.008</pub-id><pub-id pub-id-type="pmid">24880634</pub-id></element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cianferoni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ruffner</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Molleston</surname>
<given-names>JM</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Food protein-induced enterocolitis syndrome food challenges: experience from a large referral center</article-title>
<source>J Allergy Clin Immunol Pract</source>
<year iso-8601-date="2019">2019</year>
<volume>7</volume>
<fpage>444</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaip.2018.09.009</pub-id><pub-id pub-id-type="pmid">30243880</pub-id></element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Infante</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Marco-Martín</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zubeldia</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Fuentes-Aparicio</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Alvarez-Perea</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cabrera-Freitag</surname>
<given-names>P</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Oral food challenge in food protein-induced enterocolitis syndrome by fish: Is there any room for improvement?</article-title>
<source>Int Arch Allergy Immunol</source>
<year iso-8601-date="2019">2019</year>
<volume>179</volume>
<fpage>215</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1159/000497486</pub-id><pub-id pub-id-type="pmid">30982049</pub-id></element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Gonzalez-Delgado</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vadas</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Food protein-induced enterocolitis syndrome: not just in children</article-title>
<source>Ann Allergy Asthma Immunol</source>
<year iso-8601-date="2021">2021</year>
<volume>127</volume>
<fpage>291</fpage>
<lpage>2</lpage>
<pub-id pub-id-type="doi">10.1016/j.anai.2021.05.029</pub-id><pub-id pub-id-type="pmid">34082126</pub-id></element-citation>
</ref>
<ref id="B41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leonard</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Pecora</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Fiocchi</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Nowak-Wegrzyn</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Food protein-induced enterocolitis syndrome: a review of the new guidelines</article-title>
<source>World Allergy Organ J</source>
<year iso-8601-date="2018">2018</year>
<volume>11</volume>
<elocation-id>4</elocation-id>
<pub-id pub-id-type="doi">10.1186/s40413-017-0182-z</pub-id><pub-id pub-id-type="pmid">29441147</pub-id><pub-id pub-id-type="pmcid">PMC5804009</pub-id></element-citation>
</ref>
</ref-list>
</back>
</article>